Overexpressed in Solid Tumors ADC Currently in a First-in-Human Study NIJMEGEN, Netherlands, April 12, 2023 /PRNewswire/ — Byondis B.V., an independent, clinical-stage Dutch biopharmaceutical company creating precision medicines, today announced that Molecular Cancer Therapeutics (an…